François Maltais, MD
Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval, Québec City, QC

Chronic hypercapnic respiratory failure is common in advanced COPD, and it is associated with adverse outcomes. Long-term non-invasive ventilation (NIV) has been used with uncertain efficacy in this condition, but recent clinical trials suggest possible survival and hospital admission rate benefits. The purpose of this presentation will be to review current evidence regarding long-term NIV in the treatment of chronic hypercapnic respiratory failure specifically related to advanced COPD. Current guideline recommendations, including the 2021 Canadian Thoracic Society Clinical Practice Guideline Update on long-term NIV in patients with COPD, will be reviewed. Lastly, we will discuss how to implement long-term NIV in stable COPD.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Describe the expected benefits of non-invasive ventilation (NIV) in stable COPD;
  • Describe the recent recommendations for the use of NIV in stable COPD, including those from the 2021 Canadian Thoracic Society Clinical Practice Guideline Update; and
  • Prescribe and adjust NIV in stable COPD.

CanMEDS Roles Addressed: Medical Expert, Professional, Scholar